← Leaderboards
Daniel Rotroff
Cleveland Clinic Lerner Com-Cwru
$3,226,445
Attributed
$8,900,787
Total exposure
3
Grants
2
Lead (contact PI)
Attributed= this PI's even-split share of every grant they're on (the fair, additive number). Exposure = full size of all those grants.
Funding over time
peak $4.8M · FY2020–24$5M$3.8M$2.5M$1.3M$0
'20
'21
'22
'23
'24
Funding mix
By agency
NIH$8,900,787 · 3
By mechanism
R61$4,775,386 · 1
R33$2,568,308 · 1
UG3$1,557,093 · 1
Top collaborators
- Joseph F Foss3 shared
- Kenward B Johnson3 shared
- Rony Roger Sayegh1 shared
Most similar at Cleveland Clinic Lerner Com-Cwru
Same institution · by research overlap
- Joseph F Foss$2,447,898
- Kenward B Johnson$2,447,898
- Rony Roger Sayegh$778,547
Others in their field
Other Emerging Leaders on “Roc Curve”
- Karen Larimer · Vgbio, Inc.$6,644,507
- Mengxiao Yu · Clearnano, Inc.$3,778,496
- Dennis G. Moledina · Yale University$2,934,865
- Timothy Perk · Aiq Solutions, Inc.$2,653,167
- Kenward B Johnson · Cleveland Clinic Lerner Com-Cwru$2,447,898
- Joseph F Foss · Cleveland Clinic Lerner Com-Cwru$2,447,898
Research focus
Roc CurveQuality Of LifeNumeric Rating ScaleResponseTherapy OutcomeChemokineMessenger RnaMonitorPredictive MarkerQuestionnairesSamplingAreaCytokineBiological MarkersAffectMachine LearningMolecularMolecular MarkerPainPainful NeuropathyBiomarker SignatureBiomarker PanelBiomarker IdentificationClinical Practice
Grant awards (4)
Multi-Omic Biomarkers for Neuropathic Pain Secondary to Chemotherapy$932,268
R33 · FY2024 · NS · contact PI
Multi-Omic Biomarkers for Neuropathic Pain Secondary to Chemotherapy$1,636,040
R33 · FY2023 · NS · contact PI
Identifying multimodal biomarkers for autologous serum tears in the treatment of chronic postoperative ocular pain$1,557,093
UG3 · FY2023 · NS
Multi-Omic Biomarkers for Neuropathic Pain Secondary to Chemotherapy$4,775,386
R61 · FY2020 · NS · contact PI